These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27847916)

  • 21. Patterns of medical management of overactive bladder (OAB) and benign prostatic hyperplasia (BPH) in the United States.
    Anger JT; Goldman HB; Luo X; Carlsson MO; Chapman D; Zou KH; Russell D; Ntanios F; Esinduy CB; Clemens JQ
    Neurourol Urodyn; 2018 Jan; 37(1):213-222. PubMed ID: 28455944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery for benign prostatic hyperplasia: Profile of patients in a tertiary care institution.
    Rajeev R; Giri B; Choudhary LP; Kumar R
    Natl Med J India; 2017; 30(1):7-10. PubMed ID: 28730999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive medications.
    Zhang LT; Lee SW; Park K; Chung WS; Kim SW; Hyun JS; Moon DG; Yang SK; Ryu JK; Yang DY; Moon KH; Min KS; Park JK
    Clin Interv Aging; 2015; 10():277-86. PubMed ID: 25653511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging Are Correlated With Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-assisted Radical Prostatectomy for Prostate Cancer.
    Grivas N; van der Roest R; Tillier C; Schouten D; van Muilekom E; Schoots I; van der Poel H; Heijmink S
    Urology; 2017 Sep; 107():196-201. PubMed ID: 28601562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study.
    Xue Z; Lin Y; Jiang Y; Wei N; Bi J
    BMC Urol; 2018 Dec; 18(1):115. PubMed ID: 30545338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia.
    Bulut S; Ozden C; Aktas BK; Deren T; Tagci S; Gokkaya CS; Baykam MM; Memis A
    Urol Int; 2015; 94(2):181-6. PubMed ID: 25139617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study.
    Lukacs B; Cornu JN; Aout M; Tessier N; Hodée C; Haab F; Cussenot O; Merlière Y; Moysan V; Vicaut E
    Eur Urol; 2013 Sep; 64(3):493-501. PubMed ID: 23465519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The frequency of surgery of benign prostatic hypertrophy].
    Janin P; Haillot O; Boutin JM; Lesourd B; Hubert B; Lanson Y
    Prog Urol; 1995 Sep; 5(4):515-21. PubMed ID: 7581501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urologic diseases in America project: benign prostatic hyperplasia.
    Wei JT; Calhoun E; Jacobsen SJ
    J Urol; 2005 Apr; 173(4):1256-61. PubMed ID: 15758764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural history of benign prostatic hyperplasia.
    Fitzpatrick JM
    BJU Int; 2006 Apr; 97 Suppl 2():3-6; discussion 21-2. PubMed ID: 16507045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of Surgical Reintervention for Benign Prostatic Hyperplasia Following Prostatic Urethral Lift, Transurethral Resection of the Prostate, and Photoselective Vaporization of the Prostate: A TriNetX Analysis.
    Feiertag JH; Kane JA; Clark JY
    Eur Urol Open Sci; 2024 Jan; 59():63-70. PubMed ID: 38298771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.
    Cowles RS; Kabalin JN; Childs S; Lepor H; Dixon C; Stein B; Zabbo A
    Urology; 1995 Aug; 46(2):155-60. PubMed ID: 7542818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey on benign prostatic hyperplasia distribution and treatment patterns for men with lower urinary tract symptoms visiting urologists at general hospitals in Korea: a prospective, noncontrolled, observational cohort study.
    Lee SH; Chung BH; Kim CS; Lee HM; Kim CI; Yoo TK; Lee KS; Park KS; Byun SS; Yoon BI; Kim SW; Lee JY
    Urology; 2012 Jun; 79(6):1379-84. PubMed ID: 22503769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Age-related androgen deficiency and benign prostatic hyperplasia: how to improve the rehabilitation of patients after transurethral surgery?].
    Martov AG; Ergakov DV
    Urologiia; 2016 Dec; (6):110-117. PubMed ID: 28248054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition).
    Zeng XT; Jin YH; Liu TZ; Chen FM; Ding DG; Fu M; Gu XQ; Han BM; Huang X; Hou Z; Hu WL; Kang XL; Li GH; Li JX; Li PJ; Liang CZ; Liu XH; Liu ZY; Liu CX; Liu JM; Luo GH; Luo Y; Qin WJ; Qiu JH; Qiu JX; Shang XJ; Shi BK; Sun F; Tian GX; Tian Y; Wang F; Wang F; Wang YH; Wang YJ; Wang ZP; Wang Z; Wei Q; Xiao MH; Xu WH; Yi FX; Zhu CY; Zhuang QY; Zhou LQ; Zou XF; Xing NZ; He DL; Wang XH; ; ;
    Mil Med Res; 2022 Apr; 9(1):14. PubMed ID: 35361280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of depression, anxiety and somatization on the clinical symptoms and treatment response in patients with symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Yang YJ; Koh JS; Ko HJ; Cho KJ; Kim JC; Lee SJ; Pae CU
    J Korean Med Sci; 2014 Aug; 29(8):1145-51. PubMed ID: 25120327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study.
    Ilo D; Raluy-Callado M; Graham-Clarke P; Sadasivan R; Birt J; Donaldson R; Zhu E; Kirby MG; Neasham D
    Int J Clin Pract; 2015 Aug; 69(8):853-62. PubMed ID: 26011100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of impact of BPH surgical treatment with the open prostatectomy and transurethral resection of the prostate methods on the quality of life.
    Milicevic S; Grubor P; Lucic N
    Med Arh; 2011; 65(5):274-7. PubMed ID: 22073850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.